| Literature DB >> 26385795 |
Ji-Eun Park1,2, Tae-young Choi3, Yeonhee Ryu4, Sung-Il Cho5,6.
Abstract
BACKGROUND: A recent systematic review reported that mild drinking showed beneficial effects on mortality. However, this relationship between alcohol consumption and mortality differs by race, and there are few studies on Koreans. In this study, we reviewed previous studies conducted on Koreans to investigate the association between mild drinking and mortality.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26385795 PMCID: PMC4575439 DOI: 10.1186/s12889-015-2263-7
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Fig. 1Flowchart of the literature search
Characteristics of studies on alcohol drinking and mortality
| First author (Year) | Study design | Study period (Follow-up duration) | Participants | Number of cases (death) | Measures of alcohol consumption | Risk estimate (Confidence Interval) | Criteria of mild drinking | |
|---|---|---|---|---|---|---|---|---|
| All cause mortality | ||||||||
| Kim 2007 [ | Cohort | 1995-2001 (6 years) | Aged ≥20 | 3,366 (228) | Status | Men | Women | n.r |
| None: 1.0 | None: 1.0 | |||||||
| Former:1.01 (0.57-1.77) | Former: 1.41 (0.62-3.05) | |||||||
|
|
| |||||||
| Rhee 2012 [ | Cohort | 1993-2008 (15 years) | Men aged 40-59 | 14,533 (990) | Status | None; 1.0 | n.r | |
| Former: 1.17 (0.98-1.39) | ||||||||
|
| ||||||||
| Park 1999 [ | Nest case–control | 1993-1997 (4–5 years) | Aged ≥40 | 38,496 (19,258) | Frequency | None: 1.0 | n.r | |
|
| ||||||||
| Frequently: 1.17 (1.1-1.26) | ||||||||
| Sull 2009 [ | Cohort | 1985-2005 (20.8 years) | Men aged ≥55 | 2,624 (1,984) | Frequency | None: 1.0 | n.r | |
|
| ||||||||
| Few time a week | ||||||||
| Daily: 1.25 (1.10-1.43) | ||||||||
| Yi 2004 [ | Cohort | 1985-1999 (14 years) | Aged ≥55 | 6,292 (2,673) | Weekly amount | Men | Women | ≤70 g/week |
| None; 1.0 | None: 1.0 | |||||||
|
|
| |||||||
| Moderate:1.09 (0.96-1.23) | Moderate:1.16 (0.77-1.74) | |||||||
| Heavy: 1.35 (1.14-1.60) | ||||||||
| Khang 2009 [ | Cohort | 1998-2001 (3 years) | Aged ≥30 | 8,366 (310) | Monthly amount | None: 1.0 | n.r | |
| Former: 2.03(1.42-2.91) | ||||||||
|
| ||||||||
| Q1: 1.04 (0.62-1.68) | ||||||||
| Q2: 1.09 (0.71-1.67) | ||||||||
| Q3: 1.17 (0.78-1.76) | ||||||||
| Q4: 1.23 (0.82-1.84) | ||||||||
| Kim 2010 [ | Cohort | 2000-2005 (5 years) | Aged 40-69 | 1,341,393 (19,375) | Daily amount | Men | Women | <30 g/day for men |
| None: 1.0 | None: 1.0 | <15 g/day for women | ||||||
|
|
| |||||||
| 15-29.9 g:0.88 (0.84-0.92) | ≥15 g: 1.39 (1.08-1.79) | |||||||
| 30-89.9 g:1.07 (1.02-1.13) | ||||||||
| ≥90 g: 1.29 (1.22-1.37) | ||||||||
| Jeong 2012 [ | Cohort | 2005-2006 (1 year) | Aged ≥65 | 997 (113) | Weekly amount | None: 1.0 | ≤7drinks/week | |
|
| ||||||||
| Moderate: 1.15 (0.46-2.85) | ||||||||
| Heavy: 1.44 (0.81-2.56) | ||||||||
| Jung 2012 [ | Cohort | 1993-2004 (11 years) | Aged ≥20 | 16,320 (1,122) | Weekly amount | None: 1.18 (0.96-1.45) | ≤90 g/week | |
|
| ||||||||
| 90.1-252 g: 1.29 (0.99-1.66) | ||||||||
| 252.1-504 g: 1.31 (1.00-1.71) | ||||||||
| ≥504.1 g: 1.39 (1.05-1.83) | ||||||||
| Cancer-related mortality | ||||||||
| Lim 2008 c [ | Cohort | 1993-1996 1995–2002 (2–7 years) | Aged ≥65 | 14,304 (112) | Status | None:1.0 | ≤24 g/day | |
| Ex: 1.47 (0.87-2.47) | ||||||||
|
| ||||||||
| Lee 2002 [ | Cohort | 1985-1998 (13 years) | Aged ≥55 | 2,681 (253) | Weekly amount | None: 1.0 | 1-4 times/month | |
|
| ||||||||
| Moderate: 1.01 (0.69-1.48) | ||||||||
| Heavy: 1.2 (0.89-1.62) | ||||||||
| Jee 2004 d [ | Cohort | 1993-2002 (7–9 years) | Aged 30-95 | 1,283,112 (3,807) | Daily amount | Men | Women | 1-24.9 g/day |
| None: 1.0 | None: 1.0 | |||||||
|
|
| |||||||
| 25-49.9 g: 1.0 (0.9-1.2) | ||||||||
| 50-99.9 g: 1.1 (0.9-1.4) | ||||||||
| ≥100 g: 1.4 (1.0-1.8) | ||||||||
| Park 2006 [ | Cohort | 1996-2004 (9 years) | Men aged ≥ 20 | 14,578 (7,271) | Weekly amount | None: 1.0 | n.r | |
|
| ||||||||
| ≥124.2 g: 1.05 (0.98-1.12) | ||||||||
| Kim 2010 [ | Cohort | 2000-2005 (5 years) | Aged 40-69 | 1,341,393 (19,375) | Daily amount | Men | Women | <30 g/day for men |
| None: 1.0 | None: 1.0 | <15 g/day for women | ||||||
|
|
| |||||||
| 15-29.9 g: 0.93 (0.87-1.0) | ≥15 g: 1.39 (1.08-1.79) | |||||||
| 30-89.9 g:1.06 (0.98-1.15) | ||||||||
| ≥90 g: 1.21 (1.11-1.33) | ||||||||
| Kimm 2010e [ | Cohort | 1993-2006 (14 years) | Aged 30-93 | 782,632 (996) | Daily amount | None: 1.0 | ≤24 g/day | |
|
| ||||||||
| 25-49 g: 2.7 (2.1-3.5) | ||||||||
| 50-99 g: 3.7 (2.8-5.0) | ||||||||
| ≥100 g: 3.4 (2.2-5.3) | ||||||||
| Yi 2010 f [ | Cohort | 1985-2005 (20.8 years) | Aged ≥55 | 6,291 (360) | Weekly amount | Men | Women | <138 g/week for men, <12 g/week for women |
| None: 1.0 | None: 1.0 | |||||||
|
|
| |||||||
| Moderate:1.06(0.73-1.56) | High: 1.63 (0.83-3.19) | |||||||
| High: 1.26 (0.88-1.82) | ||||||||
| Jung 2012 [ | Cohort | 1993-2004 (11 years) | Aged ≥20s | 16,320 (1,122) | Weekly amount | None: 1.55 (1.15-2.11) | ≤90 g/week | |
|
| ||||||||
| 90.1-252 g: 1.7 (1.16-2.49) | ||||||||
| 252.1-504 g: 1.84 (1.24-2.72) | ||||||||
| ≥504.1 g: 2.07 (1.39-3.09) | ||||||||
| Cardiovascular mortality | ||||||||
| Meng 1987 [ | Case–control study | 1982-1983 | Aged 35-65 | 910 (190) | Frequency | None: 1.0 | 1-2 times/month | |
|
| ||||||||
| 1-2 times/week: 1.09 | ||||||||
| 3-4 times/week: 2.27 | ||||||||
| Everyday: 2.17 | ||||||||
| Sull 2009 [ | Cohort | 1985-2005 (20.8 years) | Men aged ≥55 | 2,624 (1,984) | Frequency | None: 1.0 | n.r | |
|
| ||||||||
| Few times a week | ||||||||
| Daily: 1.36 (1.0-1.84) | ||||||||
| Yi 2004 [ | Cohort | 1985-1999 (14 years) | Aged ≥55 | 6,292 (672) | Weekly amount | Men | Women | ≤70 g/week |
| None: 1.0 | None: 1.0 | |||||||
|
|
| |||||||
| 70-503.9 g: 1.06 (0.8-1.39) | ≥70 g: 0.89 (0.33-2.4) | |||||||
| ≥504 g: 1.52 (1.06-2.19) | ||||||||
BP: blood pressure, FBS: fasting blood sugar, n.r: not reported, a: almost daily plus 2 to 3 times a week, b: 1 to 4 times a month, c: Colorectal cancer, d: Hepatocellular carcinoma, e: Esophageal cancer, f: Digestive cancer. The group in bold font was analyzed in review or meta-analysis
Fig. 2Pooled results of mild drinking on the risk of all-cause mortality
Fig. 3Pooled results of mild drinking on the risk of cancer-related mortality. a All-cancer mortality. b Mortality from all-cancer and specific type of cancer
Fig. 4Funnel plot for alcohol consumption in relation to all-cause mortality and cancer-related mortality. a All-cause mortalit`y. b All-cancer mortality. c Mortality from all-cancer and specific type of cancer